Bovine Babesiosis: Babesia bovis and Babesia bigemina Infections (Tick Fever)

Introduction

Bovine babesiosis, commonly referred to as tick fever, is a globally significant haemoprotozoan disease of cattle caused principally by Babesia bovis and Babesia bigemina. These intraerythrocytic apicomplexan parasites are transmitted by ixodid ticks, primarily Rhipicephalus microplus, and impose substantial economic losses on livestock production in tropical and subtropical regions [1, 2, 3]. The disease is characterized by fever, anaemia, haemoglobinuria, and in the case of B. bovis, cerebral signs due to sequestration of infected erythrocytes in capillaries [4]. Molecular surveys continue to reveal high prevalence and genetic diversity of these pathogens across Africa [3, 5, 6], Asia [1, 7, 8], the Americas [9, 10, 11], and the Middle East [12, 13, 14]. Understanding the biological and epidemiological features of B. bovis and B. bigemina is essential for designing effective diagnostic, therapeutic, and control strategies.

Etiology

Babesia bovis and Babesia bigemina are obligate intraerythrocytic parasites of the phylum Apicomplexa, order Piroplasmida. Babesia bovis is the more virulent species, causing severe cerebral babesiosis due to cytoadhesion of infected erythrocytes to vascular endothelium. Babesia bigemina typically induces a milder haemolytic anaemia but can still lead to significant morbidity and mortality, especially in naive adult cattle [4, 15]. Both species undergo asexual replication within bovine erythrocytes, producing merozoites that lyse the host cell and reinvade new erythrocytes. Sexual reproduction occurs within the tick vector, leading to transovarial transmission [16, 17].

Recent work has elucidated molecular mechanisms of parasite-host interactions. Enolase of B. bigemina binds plasminogen and contains conserved B-cell epitopes that induce neutralizing antibodies in cattle [18]. Transcriptomic analysis of R. microplus hemocytes infected with B. bovis or B. bigemina reveals differential expression of immune-related genes [17]. Comparative immune response gene profiling between virulent and attenuated strains of B. bigemina has identified potential targets for vaccine development [19]. Cryopreservation protocols for attenuated parasites have been improved to support live vaccine production [20].

Epidemiology and Transmission

Transmission of B. bovis and B. bigemina is primarily mediated by Rhipicephalus microplus (formerly Boophilus microplus), a one-host tick that feeds predominantly on cattle. Transovarial transmission ensures that larvae emerging from an infected female tick are capable of transmitting babesiosis to a naive host [16]. Other tick species, including Rhipicephalus decoloratus and Haemaphysalis longicornis, may serve as vectors in certain regions, although H. longicornis has been shown to be incompetent for B. bigemina transmission [16, 5]. Mechanical transmission by horseflies has also been documented, with B. bigemina DNA detected in tabanids in Uruguay [21]. The presence of multiple tick-borne pathogens in cattle ticks from various regions underscores the complexity of co-infections [22, 23, 24].

Epidemiological studies using molecular diagnostics have revealed widespread infection in cattle across the tropics. In Tripura, India, a high prevalence of B. bigemina and B. bovis was reported [1]. In the Imbo region of Burundi, risk factors such as age, breed, and tick control practices were associated with Babesia spp. infection [2]. South African studies indicate that Babesia infections are common and often occur as mixed infections with Anaplasma marginale [3]. In Brazil, tick fever risk is influenced by biome and management practices, with the Atlantic Forest biome showing particular enzootic stability [9]. Similarly, a comparative analysis in northeast Brazil found distinct prevalence patterns across tropical humid and semi-arid regions [10]. In Uganda, a systematic review and meta-regression highlighted high variability in prevalence depending on region and livestock management [25]. Other prevalence reports from Egypt [12, 13], Thailand [7, 26], Pakistan [27], Ethiopia [28], Iraq [14], and Mozambique [6] confirm the global distribution of these parasites. Water buffaloes can also harbour Babesia spp. and may serve as reservoirs [29, 26].

Clinical Signs and Pathology

The clinical presentation of bovine babesiosis varies between the two species due to differences in pathogenesis.

Babesia bovis infection is characterized by acute fever (40-42 degrees C), profound anaemia, haemoglobinuria, and neurological signs such as ataxia, circling, and recumbency. The hallmark pathology is cerebral babesiosis, caused by sequestration of parasitized erythrocytes in cerebral capillaries, leading to hypoxia and oedema. Postmortem findings include icterus, dark-coloured urine, splenomegaly, and a congested brain with a characteristic "cherry-red" appearance. Immunopathological mechanisms involve chemokine mediators and toll-like receptor expression [30].

Babesia bigemina infection typically presents with high fever, anaemia, and haemoglobinuria, but without the cerebral component. The disease is generally less severe, although mortality can occur in susceptible adult cattle. Both species can cause abortion in pregnant cows. Chronic infections may lead to persistent low-level parasitaemia and poor growth performance.

Diagnostics

Accurate and timely diagnosis is critical for managing bovine babesiosis. Traditional methods include microscopic examination of Giemsa-stained blood smears, which can detect intraerythrocytic piroplasms. Babesia bovis appears as small (1.0-2.5 micrometre) paired merozoites often at the periphery of erythrocytes, while B. bigemina is larger (2.5-5.0 micrometre) and more centrally located. Microscopy is inexpensive but lacks sensitivity in low-parasitaemia infections and cannot reliably differentiate species [15, 14].

Molecular diagnostics have become the gold standard due to their high sensitivity and specificity. Conventional PCR and real-time PCR assays targeting the 18S rRNA gene or species-specific genes (e.g., B. bovis spherical body protein, B. bigemina gp45) are widely used [1, 7, 31, 32]. A real-time SYBR green PCR method has been developed for simultaneous detection and differentiation of Babesia and Theileria species in ticks and cattle blood [31]. Loop-mediated isothermal amplification (LAMP) and CRISPR-based approaches are emerging as field-deployable alternatives [15]. Point-of-care molecular diagnostic devices are under development for resource-limited settings [15].

Serological tests, including indirect immunofluorescence assays (IFAT) and enzyme-linked immunosorbent assays (ELISA), can detect antibodies to B. bovis and B. bigemina. Recombinant antigens such as gp45 of B. bigemina have been expressed and used to evaluate immunogenicity in cattle [33]. These tests are useful for epidemiological surveys and for assessing exposure history, but they cannot distinguish active from past infection.

The TFinder smartphone application represents a novel artificial intelligence tool for automated diagnosis of tick fever agents and assessment of parasitaemia in bovine blood smears [34]. This technology may enhance field diagnostics in the future.

Treatment

Treatment of bovine babesiosis relies on babesiacidal drugs. Imidocarb dipropionate is the most widely used agent; it is effective against both B. bovis and B. bigemina and also has some prophylactic activity. A single dose of 1-2 mg/kg body weight subcutaneously is typical for treatment, with a higher dose (3 mg/kg) used for chemoprophylaxis. Diminazene aceturate is another commonly used treatment, particularly against B. bigemina, but it has a narrower safety margin and is less effective against B. bovis. Supportive care includes blood transfusions in severe anaemic cases, fluid therapy, and anti-inflammatory agents. Strategic tick control using acaricides (e.g., fluralaner) can reduce transmission pressure and maintain enzootic stability [35]. Plant-based acaricides such as chrysanthemum extract and neem oil emulsion have been investigated as alternatives [36].

Control and Prevention

Control of bovine babesiosis integrates tick management, chemoprophylaxis, and vaccination. Tick control through the use of acaricides (pour-ons, sprays, dips) remains the mainstay, although resistance to synthetic pyrethroids and organophosphates is widespread. Anti-tick vaccines targeting antigens such as Bm86 (the gut antigen of R. microplus) have been deployed in some countries, but their efficacy varies [37]. The VDAC protein of R. microplus has been identified as a plasminogen-binding protein and may serve as a novel vaccine target [38].

Live attenuated vaccines for B. bovis and B. bigemina are used in several endemic regions, including Australia, South Africa, and South America. These vaccines consist of blood-derived parasites that have been passaged in splenectomized calves to reduce virulence. Cryopreservation methods have been optimized to maintain vaccine viability [20]. A systematic review and meta-analysis of six decades of research on bovine babesiosis vaccines provides comprehensive data on efficacy and safety [4]. Recombinant subunit vaccines are under development; for instance, the gp45 protein of B. bigemina has shown immunogenicity in cattle [33], and enolase epitopes are being explored [18].

Genetic selection of cattle with innate resistance to babesiosis, such as Bos indicus breeds and certain Creole breeds, is a complementary approach. The BoLA-DRB3 gene has been associated with resistance or susceptibility to Babesia spp. infections in Colombian Creole cattle [11]. Enzootic stability is a desirable epidemiological state where calves are infected during the first months of life and develop immunity without clinical disease. Strategic tick control aiming to maintain this balance is a key management goal in endemic areas [9, 35].

flowchart TD
    A[Clinical suspicion of bovine babesiosis], > B{Blood smear microscopy}
    B, >|Positive: piroplasms detected| C[Species identification by PCR]
    B, >|Negative but high suspicion| D[Molecular testing: PCR or LAMP]
    C, > E[Species-level diagnosis achieved]
    D, >|Positive| C
    D, >|Negative| F[Consider serology for exposure history]
    E, > G[Treatment: imidocarb or diminazene]
    G, > H[Supportive care if severe]
    H, > I[Implement tick control and vaccination]
    I, > J[Monitor herd for enzootic stability]

Conclusion

Bovine babesiosis caused by Babesia bovis and Babesia bigemina remains a major constraint to cattle production in the tropics. Advances in molecular diagnostics, vaccine development, and tick control strategies are improving disease management. Continued surveillance using sensitive molecular tools is essential to track the distribution and genetic diversity of these parasites and to guide control programmes tailored to local epidemiological conditions.

References

[1] Debbarma A, Pandit S, Tewari AK et al. Prevalence and molecular characterization of tick-borne cattle haemoparasites in Tripura, India. Trop Anim Health Prod. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42258062/

[2] Ndayikengurukiye E, Ntirandekura JB, Nyabongo L et al. Molecular epidemiology and risk factors associated with Babesia spp infections in cattle in Imbo region, Burundi. J Parasit Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42226911/

[3] Bambeni T, Byaruhanga C, Stoltsz WH et al. Epidemiological insights into bovine babesiosis in South African cattle. Parasitol Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42095911/

[4] Valdez-Espinoza UM, Pérez-Almeida C, Cárdenas-Flores A et al. Six Decades of Global Research on Bovine Babesiosis Vaccines: A Comprehensive Systematic Review and Meta-Analysis. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198626/

[5] Chikufenji B, Mohanta UK, Chatanga E et al. Unveiling the tick-borne pathogens from domestic ruminant ticks in Malawi and the emergence of the brown ear tick in the southern region: implications for East Coast fever control. Parasite. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41995167/

[6] Secato CT, Matos CA, Calchi AC et al. Genetic diversity of Ehrlichia sp., Babesia spp., and Anaplasma marginale in cattle from Mozambique. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741034/

[7] Bhadury P, Do T, Pilean N et al. Molecular Prevalence and Genetic Characterization of Bovine Tick-Borne Protozoa in Thai and Imported Beef Cattle in Thai-Myanmar Border and Infesting Ticks from Kanchanaburi Province, Thailand. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42075692/

[8] Ravindran R, Kumar KGA, Deepa CK et al. Molecular epidemiology of tick-borne infections of bovines and canines of India – Current status. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651013/

[9] Puentes JD, Machado RZ, de Souza Perinotto WM et al. Tick fever risk and factors influencing the transmission of Anaplasma marginale, Babesia bovis and Babesia bigemina in cattle properties from Atlantic Forest biome. Trop Anim Health Prod. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41615537/

[10] Alvares FBV, Silva JO, Lima Neto BF et al. Epidemiological Spectrum of Bovine Tick-Borne Pathogens in Northeast Brazil: Comparative Analysis Across a Tropical Humid and Two Semi-Arid Regions. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41598999/

[11] Jaimes-Dueñez J, Marin-Cossio L, Gongora-Orjuela A et al. Genetic diversity of BoLA-DRB3 and its association with Anaplasma marginale and Babesia spp. infections in creole cattle of northeastern Colombia. Vet Parasitol Reg Stud Reports. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41242792/

[12] Hassan MR, Abdullah HHAM, El-Maadawy RS et al. Molecular detection and distribution of piroplasms and Anaplasma species and their co-infections in cattle from three Egyptian governorates. Vet Parasitol Reg Stud Reports. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41242787/

[13] Barghash SM, Elnaga TRA, Osman WAL et al. Detection and genotypes of piroplasms affecting ruminants in the New Valley Governorate, Egypt. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41241745/

[14] Mahmood SL, Ahmed RB, Kakarash NA et al. Microscopic and molecular studies of bovine Babesiosis in Sulaymaniyah, Iraq. Vet Parasitol Reg Stud Reports. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39855877/

[15] Dasanayaka BP, Pathirana SL, Jayawardana A et al. A roadmap in detecting frequently reported bovine babesiosis: From blood smear to CRISPR. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41344285/

[16] Poh KC, Aguilar M, Capelli-Peixoto J et al. Haemaphysalis longicornis (Acari: Ixodidae) failed to acquire and consequently transmit Babesia bigemina to naïve cattle. Ticks Tick Borne Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42140107/

[17] Vimonish R, Capelli-Peixoto J, Johnson W et al. Transcriptomic analysis of Rhipicephalus microplus hemocytes from female ticks infected with Babesia bovis or Babesia bigemina. Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39901199/

[18] Laura LA, Juan M, Jacqueline CE et al. Babesia bigemina enolase binds to plasminogen and contains conserved B-cell epitopes that induce neutralizing antibodies in cattle. Vet Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40403476/

[19] Martínez-García G, Estrada K, Lira-Amaya JJ et al. Comparative Analysis of Immune Response Genes Induced by a Virulent or Attenuated Strain of Babesia bigemina. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39859202/

[20] Rojas-Martínez C, Lira-Amaya JJ, Ueti MW et al. Improvement of Cryopreservation and Production of Attenuated Babesia Parasites to Prevent Bovine Babesiosis. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40430817/

[21] Morales DF, Parodi P, Dos Reis LFV et al. First molecular detection of Babesia bigemina in horseflies from Uruguay. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40139550/

[22] Deng YP, Liu YL, Zhang Y et al. First molecular evidence of Rickettsia massiliae and R. slovaca in Rhipicephalus microplus ticks from China. Acta Trop. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41490748/

[23] Nonthapa A, Rodpai R, Thanchomnang T et al. Molecular detection of tick-borne pathogens in cattle ticks from the Lao People's Democratic Republic. Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41351125/

[24] Wang B, Liu Z, Zhu S et al. Molecular characterization of tick-borne bacterial and protozoan pathogens in parasitic ticks from Xinjiang, China. Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40468420/

[25] Wasswa AT, Rascón-García K, Kakuru M et al. Systematic review and meta-regression analysis of the prevalence of tick-borne pathogens in ticks and livestock in Uganda from 1980 to 2024. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41469448/

[26] Sansamur C, Boonchuay K, Ngasaman R et al. Epidemiology and factors associated with the infection of Babesia bigemina, Babesia bovis, and Theileria orientalis in Thale Noi Wetland buffaloes (Bubalus bubalis), Southern Thailand. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40452065/

[27] Wahab M, Hafeez MA, Aslam F et al. Prevalence in Relation to Risk Factors of Babesia Bigemina in Bovines of Punjab (Pakistan). Acta Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41148442/

[28] Yenew AS, Dagnachew Nigatu S, Seyoum Z et al. Epidemiology of Ticks and Tick-Borne Hemopathogens of Cattle in Two Selected Districts of Northwest Ethiopia. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40028802/

[29] Secato CT, Gonçalves LR, Ramos IAS et al. Molecular detection of vector-borne agents in water buffaloes (Bubalus bubalis) and associated ectoparasites from Brazil. Trop Anim Health Prod. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40515935/

[30] Sarti MB, de Souza GM, Agostinho CF et al. Expression patterns of chemokine mediators and TLR10 in natural bovine babesiosis and anaplasmosis infections. Ticks Tick Borne Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40974642/

[31] Kyaw MT, Janwan P, Thanchomnang T et al. Development and validation of a real-time SYBR green PCR method for the detection and differentiation of Babesia and Theileria species (Apicomplexa: Piroplasmida) in hard ticks and cattle blood from Thailand. Parasite. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40857596/

[32] Kazim AR, Low VL, Houssaini J et al. Molecular screening of Babesia, Hepatozoon, and Theileria (Apicomplexa: Piroplasmida) in ticks (Acari: Ixodidae) infesting farm ruminants in Peninsular Malaysia. Trop Biomed. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39876494/

[33] Zia-Ul-Rehman, Sarfraz-Ur-Rahman, Ashraf K et al. Expression and characterization of the immunogenicity of rec-gp45 of Babesia bigemina using cattle. Trop Anim Health Prod. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40032701/

[34] Trindade ASN, de Moraes IML, Leal LLLL et al. TFinder App: Artificial intelligence to diagnose tick fever agents and assess parasitemia/bacteremia in bovine blood smears. Vet Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39938255/

[35] de Aquino LM, de Morais IML, Salvador VF et al. Does fluralaner (Exzolt(®) 5%) affect the enzootic stability of tick fever in beef calves subjected to strategic tick control in a tropical region? Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41107963/

[36] Abd-Elrahman SM, Kamel FA, Abdel-Hakeem SS et al. Piroplasm infestations in cattle: exploring tick control using Chrysanthemum extract and neem oil emulsion. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40230792/

[37] Busch JD, Stone NE, Pemberton GL et al. Fourteen anti-tick vaccine targets are variably conserved in cattle fever ticks. Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40234925/

[38] Castañeda-Ortiz EJ, Amaro-Ibarra M, Morales-Reyna M et al. The VDAC Protein of Rhipicephalus microplus (BmVDAC) Binds To and Enhances the Activation of Plasminogen. Acta Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41105371/

[39] Silva-Ramos CR, Niño Rodríguez JA, Gil-Mora J et al. Babesia spp. in Domestic Animals from Rural Areas of Cauca Department: Previous Exposure and Molecular Detection Among Canines, Bovines and Equines. Acta Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41239073/

[40] Gabriel ANA, Wang XY, Fornah L et al. Tick Diversity, Emerging Tick-Borne Pathogens, and Public Health Implications Across Africa: A Systematic Review. Acta Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41238920/

[41] Lombardi MC, Colácio N, de Valgas E Bastos C et al. First molecular detection of Anaplasma marginale, Babesia bovis, and hemotropic Mycoplasma spp. in bovine colostrum. Ticks Tick Borne Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41076773/

[42] Cossu CA, Quan M, Collins N et al. Widespread infections with bacterial and protozoan tick-borne pathogens in 22 wildlife species across South African game reserves. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40882860/

[43] Etiang P, Kamusiime M, Wamala H et al. Prevalence and seasonal variation of tick-borne haemoparasites in cattle from north-eastern Uganda. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40830548/

[44] Orkun Ö, Gündoğdu MN, Özdemir T et al. Phylogeographic investigation of tick-borne pathogens in host-seeking Dermacentor marginatus in Anatolia: Significant correlation between population genetic structure and SFG rickettsiae. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40617274/

[45] Casa MDS, Vettori JM, de Souza KM et al. Prevalence and factors associated with Babesia bigemina infection in Crioula Lageana cattle breed. Rev Bras Parasitol Vet. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40197948/

[46] Wu G, Zhou X, Guo F et al. Babesia infection in cattle and dogs in Suizhou City, Hubei Province, China. Infect Med (Beijing). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40129442/